Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
QASGD Associated Member
After obtaining his degree in Radio-Oncology at the University of Liege, Belgium, Jacques Bernier completed his training at the MD Anderson Cancer Center, Houston, and the Curie Institute, Paris. In 1988 he moved to Switzerland, where he was appointed Chairman of the Radio-Oncology Division, Tessin Cantonal Hospital. In 1995 he received a Privat-Docent Chair from the Geneva University. He founded, in the early 2000’s, IOSI – Oncology Institute of Southern Switzerland, in Bellinzona. In 2006 he joined the Swiss Genolier Medical Network, where since then he has been chairing the Radio-Oncology Department. Throughout most of his career, Jacques Bernier has been heavily involved with translational and clinical research. In 1993 he received the Yalow-Berson Award, in St Louis, USA, for his laboratory work on interferons and interleukins. In 2010, Jacques Bernier was awarded the “Claudius Regaud Medal” by the European Society of Therapeutic Radiology and Oncology - ESTRO. A Course Director at the European School of Oncology since 1990, Jacques Bernier is also the Chairman of the International Conference on Translational Research in Radio-Oncology - ICTR, organized every 2 years in Switzerland. In 2009, he pioneered the use of intra-operative radiotherapy for breast cancer, in Switzerland (IORT). In 2014, he created the Genolier Swiss Oncology Network (GSON), and in 2016, he received the accreditation from the Swiss Cancer Network as member of the core team of the GSON. He is currently member of the Board of the Genolier Breast Unit, accredited by the Swiss Society of Senology. In July 2016, he was elected President of the Euro-Asian Society of Mastology – EURAMA.
Last update: 2018